OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 09/15/2023
Week ended 09/15/2023
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 09/15/2023
- The Largest Closed M&A Deal of the Week:
- On September 11, 2023, Seed Innovations, an Australian investment firm focusing on early-stage health, wellness, and medical cannabis, disclosed that it had sold a 56% interest in Berlin-based medical cannabis firm Avextra. The sale reduced Seed’s stake in Avextra to around 3%.
- The transaction consideration of $3.11M was paid in cash.
- The sale gave Seed a 62% return on its original investment in Avextra.
Week ended 09/15/2023
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.